J.W.S Setoh, J.Y.H Lee, G.Y Chen,L.Y.Q Kwek, E.T.H Tan

Slides:



Advertisements
Similar presentations
FDA QS reg/CLIA Comparison: Overview
Advertisements

HIV Drug Resistance Training
Point of Care Testing: Hemoccult ® Fecal Occult Blood
Unit 5: Choosing an HIV Test
BJH POCT Hemochron Annual Competency
QUALITY CONTROL IN HEMATOLOGY
Bowel cancer screening in Learning Disability patients in Salford Nadia Awan (CT2) Rupa Gupta (ST5) Nasim Chaudhry (Consultant Psychiatrist)
Nursing and Lab partnering to perform
1 1 Chapter 1 Specimen Management Professor A. S. Alhomida Disclaimer The texts, tables and images contained in this course presentation (BCH 376) are.
Copyright © 2005 Thomson Delmar Learning. ALL RIGHTS RESERVED.1 This product was funded by a grant awarded under the President’s Community-Based Job Training.
1 The aim…. ‘to enable assessors to objectively assess a laboratory’s compliance with the new standards’
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Good laboratory practices with waived test systems
E.S.K Loh 1 J.Y.H Lee 1 R.Y.L Yong 1 J.W.S Setoh 1 1)Department of Pathology and Laboratory Medicine, KK Women’s & Children’s Hospital, Singapore Process.
Deidra Huckabee MSN, RN, CCRN. Research Question Medical ICU staff inquired about the accuracy of utilizing the bedside Point of Care Testing (POCT) analyzer.
CDRH Review Practice for Over-the-Counter in Vitro Diagnostic Tests
OnSite FOB Rapid Test A specific and sensitive colorectal cancer screening test.
Medical Parasitology Lab.
Audit of Faecal Occult Blood requests Clinical Biochemistry North Bristol NHS Trust ACB SW and Wessex Audit Meeting Thursday 17 th November 2011 Kerry.
For Medical Clinical Staff WellOne Primary Medical and Dental Care Click here to move on.
COST CONCIOUSNESS PROJECT FECAL OCCULT BLOOD TEST (FOBT) – APPROPRIATE OR NOT APPROPRIATE? by Kelvin Nguyen 05/10/2013.
J.W.S Setoh, J.Y.H Lee, G.Y Chen,L.Y.Q Kwek, E.T.H Tan KK Women’s and Children’s Hospital (SingHealth) Process Improvement With Use of Hemosure Immunochemical.
OnSite FOB Rapid Test. Hemoglobin Variants Hemoglobin variantsHemoglobin variants are a part of the normal embryonicembryonic and fetal development, but.
Patient Identification & Specimen Collection How Proper Patient Identification and Proper Specimen Collection Affects the Accuracy of Your Patient’s Laboratory.
WORK TO BE DONE. Time line March-May 2013-Preparation June 2013-November Data collection December 2014-February Analysis and report preparation.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Bashir Farah 1*, Pole Lewa 1, Bernard Omondi 1, Omu Anzala 1 1 KAVI-Institute of Clinical Research (ICR), University of Nairobi, Assessment of the Temperature.
Procedure for the Collection, Handling, and Marking of Blood and Urine Evidence in OVI Cases.
Hossein Baniamerian Kermanshah University of Medical Science
Assessment of Care Transitions (ACT) Dr. Ayse P. Gurses Dr. Mahiyar Nasarwanji.
Histopathology Specimens Are you using the correct request form? Histopathology Specimens Are you using the current histopathology request form? The request.
The Importance of Stool Occult Blood Tests in Getting to 80% Durado Brooks, MD, MPH Director, Cancer Control Interventions American Cancer Society.
Step What happens?. Who is responsible? Procedures needed?
Quality Education for a Healthier Scotland Blood Cultures.
Module Three: Identifying your Patient in SIS. Introduction – Search for 1 st T Specimen The Search for 1 st T Specimen screen is used to access your.
Sample Collection Training Guide. Sample Collection Overview It is the responsibility of the transfusing facility to collect and properly label blood.
Update for nurses and phlebotomists taking blood samples for Transfusion in General Practice The Hospital Transfusion Team
Triangulation of Qualitative Methods* We used qualitative methods to describe these steps and interfaces, how activities of patients, providers, and clinic.
Effectiveness of risk management process towards error reduction in the laboratory at Sakra World Hospital AUTHORS: Dr. Shabnam Roohi Mr. Deepak Agarkhed.
Lecture 1 clinical practice of Microbiology Specimen Management Guide Dr. Dalia galal.
Highlights on the monitoring and control of preanalytical variables By Mohamed Osama Ali Assistant lecturer of clinical pathology Faculty of medicine Suez.
Methodologies and Regulations in Specimen Collection and Management Introduction.
Laboratory diagnoses of infections agents. DIFFERENT TYPES OF AND APPROACHES TO CLINICAL SAMPLE COLLECTION.
CHLAMYDIA / GONORRHEA Vaginal Specimen Collection and Form Training NC State Laboratory of Public Health 2015.
A Pharmacy Based Bowel Cancer Screening Program. Did You Know? Bowel cancer kills more Australians each year than breast or prostate cancer (AIHW 2012.
LABORATORY TESTING.
Immunochemical Fecal Occult Blood Testing
Electronic Lab requests – Why ? How ? When ?
QUALITY MANAGEMENT Suzanne Kamel-Mohamed PhD, MBA, MT (ASCP) Associate
HCV by PCR Neelam Gajjar 7/26/2009.
Pre-Analytical Variables
Biomarker Screening Pilot
Provider Initiated HIV Counseling and Testing
Histopathology Specimens
Title Detection of HLA-B*58:01 with TaqMan assay and its association with allopurinol-induced sCADR.
Shaimah Al-Failakawi Al Amiri Hospital Laboratory Quality Manager
URINALYSIS DIPSTICK TESTING
THE OPTIONAL GENETIC STUDY
Dr Rob Palmer – CCG Gastro Lead
Quality System Considerations for Over-The-Counter HIV Testing
Tuda G Kemri/Wellcome Trust Research Program
Electronic Lab requests – Why ? How ? When ?
Jessica Gentry Tuberculosis Laboratory Supervisor
BOWEL CANCER SCREENING IN LEWISHAM
HIV-1 Rapid Test for Recent Infection
Postanalytical Phase of Laboratory Testing
FECAL OCCULT BLOOD TESTING USING SERACULT SLIDES
ORDER > BOOK IN > BOOK OUT
URINALYSIS DIPSTICK TESTING
HIV-1 Rapid Test for Recent Infection
Presentation transcript:

Process Improvement With Use of Hemosure Immunochemical Faecal Occult Blood Test J.W.S Setoh, J.Y.H Lee, G.Y Chen,L.Y.Q Kwek, E.T.H Tan KK Women’s and Children’s Hospital (SingHealth) INTRODUCTION Before November 2013, KK Women’s and Children’s Hospital (KKH) used the Guaiac-based Hemoccult Sensa test (GBHST) for Faecal Occult Blood (FOB) test for the Women Wellness Health Screening Program at The Private Suite (TPS). iFOBT KIT In November 2013, a new FOB test, Hemosure Immunochemical Faecal Occult Blood Test (iFOBT) was introduced. This new test employs the immunoassay method. With the introduction of the new iFOBT test kit we have addressed patient safety issues and brought improvement in FOB testing at KKH. METHODOLOGY Using GBHST, patients would received stool collection containers with patient identification labels by post before their appointments. At TPS, the staff would affixed test labels on the patients’ faecal containers before dispatching them to the laboratory. In November 2013, we evaluated iFOBT and decided to replace GBHST. With the change to iFOBT, TPS reviewed it’s workflow. TPS staff now send an electronic messages to remind patients on proper stool collection using appropriate containers or Ziplock bag. At TPS each patient will be given a special iFOBT-tube containing an application stick and an extraction buffer. The patient will insert the stick into the stool sample, return the stick into the tube, cap and mix the sample with the buffer. TPS staff will then affix test ordering labels and dispatch the iFOBT-tubes to the laboratory. A survey was carried out for the laboratory staff, the clinic staff and the patients on their use of iFOBT two months before and after its introduction. Graph 3. TPS Patient Satisfaction survey TPS send stool collection bottles to patient before appointment Call patient to inform about stool collection criteria and dietary restriction Patient arrive at TPS with Stool Patient did not collect stool with TPS stool container Transfer stool to proper stool container Affix Order Labels and send specimen to the lab Before GBSHT Test Kit TPS send an e-SMS to patient 3 days before appointment with instruction for stool collection. No Dietary restriction Patient insert stick into the collected stool Affix CPOE Labels and send iFOBT tubes to the lab. Patient arrive at TPS with Stool After iFOBT Test Kit Fig 3. TPS Past Workflow Fig 4. TPS Present Workflow RESULTs GBHST can be affected by dietary peroxidases, animal blood or ascorbic acid, patients had to avoid red meat, drugs and vitamins three days before stool collection. After collection, they had to refrigerate the containers to minimise specimen degradation. Intrinsic colour of the stool specimens can affect the interpretation of the GBHST by laboratory staff. iFOBT detects lower levels of FOB than the GBHST (more sensitive). iFOBT result is not affected by the intrinsic faecal colour or by dietary peroxidases, animal blood or ascorbic acid. Further, the stool samples can be stored at room temperature up to fourteen days. The change in workflow had yielded excellent feedbacks from patients, TPS staff and laboratory staff. Patients need not wait for stool containers via mail. The collected stool specimens need not be refrigerated. Patients need not observe dietary restriction prior to testing. Laboratory staff members are able to interpret the test more accurately with iFOBT and they experience improved ease in processing of stool specimens. The clinic staff has simplified specimen labelling: they only need to label the iFOBT-tubes. TPS do not need to receive stool containers with leaked faecal material. The use of iFOBT-tubes has overcome the foul faecal smell in the treatment room. Application Stick Extraction Buffer SAMPLE SMS Fig 1. iFOBT Test Kit Fig 2. TPS Sample SMS to Patient CONCLUSION By changing to iFOBT, we have improved the accuracy of FOB test at KKH, reduced pre-analytical errors and addressed the problems encountered with the GBHST method. Graph1. TPS staff Satisfaction survey Graph2. Lab staff Satisfaction survey